(0.23%) 5 111.92 points
(0.34%) 38 369 points
(0.29%) 15 974 points
(-1.32%) $82.74
(6.40%) $2.05
(-0.06%) $2 345.80
(-0.24%) $27.47
(3.94%) $958.45
(-0.22%) $0.933
(-0.34%) $10.99
(-0.53%) $0.796
(1.65%) $93.39
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 4.84%
Live Chart Being Loaded With Signals
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States...
Stats | |
---|---|
Dagens volum | 849 170 |
Gjennomsnittsvolum | 3.04M |
Markedsverdi | 98.66M |
EPS | $0 ( 2024-03-06 ) |
Neste inntjeningsdato | ( $-3.65 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.130 |
ATR14 | $0.00700 (0.37%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-07 | Glessner Coleen | Sell | 585 | Common Stock |
2024-04-07 | Hartzel William | Sell | 665 | Common Stock |
2024-03-13 | Papa Joseph C | Buy | 750 000 | Employee Stock Options (Right to Buy) |
2024-03-13 | Williams Paul Anthony | Buy | 125 000 | Employee Stock Options (Right to Buy) |
2024-03-13 | Glessner Coleen | Buy | 125 000 | Employee Stock Options (Right to Buy) |
INSIDER POWER |
---|
95.70 |
Last 100 transactions |
Buy: 2 920 145 | Sell: 69 613 |
Volum Korrelasjon
Emergent BioSolutions Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
ZVIA | 0.855 |
EHC | 0.845 |
CRT | 0.841 |
TJX | 0.832 |
E | 0.829 |
ACI | 0.828 |
CORN | 0.828 |
CWAN | 0.828 |
MVO | 0.827 |
CVEO | 0.826 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Emergent BioSolutions Inc Korrelasjon - Valuta/Råvare
Emergent BioSolutions Inc Økonomi
Annual | 2023 |
Omsetning: | $1.05B |
Bruttogevinst: | $292.50M (27.88 %) |
EPS: | $-14.85 |
FY | 2023 |
Omsetning: | $1.05B |
Bruttogevinst: | $292.50M (27.88 %) |
EPS: | $-14.85 |
FY | 2022 |
Omsetning: | $1.12B |
Bruttogevinst: | $427.20M (38.11 %) |
EPS: | $-4.47 |
FY | 2021 |
Omsetning: | $1.79B |
Bruttogevinst: | $1.04B (57.75 %) |
EPS: | $4.32 |
Financial Reports:
No articles found.
Emergent BioSolutions Inc
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to for inhalational anthrax; reactive skin decontamination lotion kits; and Trobigard, a combination drug-device auto injector product candidate; and Trobigard, a combination drug-device auto injector product candidate. The company also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine to treat cholera. In addition, it is developing AP003, a Naloxone multidose nasal spray; AP007, a sustained release Nalmefene injection for treatment of opioid use disorder; AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; COVID-HIG for the treatment of SARS-CoV2; EGRD-001, a diazepam auto-injector; SIAN, an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. Further, the company provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.